Last Fall, a study was presented in Atlanta GA, I believe, about a new approach (earlier treatment) to treatment with rising PSA following prostatectomy by Alan Pollack, MD, PhD, Chair of Radiation Oncology at the University of Miami and Deputy Director of the Sylvester Comprehensive Cancer Center.
The study has not yet been published yet but produced the following:
At 5 years following treatment, Freedom From Progression rates in the interim analysis group were
• 71.1% for PBRT alone (Prostate Bed Radiation Therapy)
• 82.7% for PBRT+ADT (Androgen Deprivation Therapy - hormone treatment)
• 89.1% for PLNRT+PBRT+ADT. (Pelvic Lymph Node Radiation Therapy)
At 8 years, distant metastasis found in:
• PBRT only - 45 patients
• PBRT+ADT - 38 patients
PLNRT+PBRT+ADT - 25 patients
It sounds like this will become the new treatment protocol for this scenario. It is the path I am now starting myself following my prostatectomy in November 2018.
Hopefully this will be helpful to someone.